HealthCor
View Older Stories View More Recent Stories
-
HealthCorps Names Omron Healthcare President & CEO Ranndy Kellogg To Board Of Directors
-
Form SC 13D/A CareView Communications Filed by: HealthCor Management, L.P.
-
Form 4 CareView Communications For: Jun 30 Filed by: HealthCor Partners LP
-
HealthCore awarded PCORI funding
-
Form 13F-HR HealthCor Partners Manag For: Mar 31
-
Form 13F-HR HealthCor Management, For: Mar 31
-
Form 4 HealthCor Partners LP For: Mar 31 Filed by: HealthCor Group, LLC
-
Form 4 CareView Communications For: Mar 31 Filed by: HealthCor Management, L.P.
-
Form SC 13D/A CareView Communications Filed by: HealthCor Management, L.P.
-
Form SC 13G Clovis Oncology, Inc. Filed by: HealthCor Management, L.P.
-
Form SC 13G/A Conatus Pharmaceuticals Filed by: HealthCor Management, L.P.
-
Form SC 13G/A Sagent Pharmaceuticals, Filed by: HealthCor Management, L.P.
-
Form SC 13G/A SeaSpine Holdings Corp Filed by: HealthCor Management, L.P.
-
Form SC 13G Corindus Vascular Roboti Filed by: HealthCor Management, L.P.
-
Form 13F-HR HealthCor Management, For: Dec 31
-
Form 13F-HR HealthCor Partners Manag For: Dec 31
-
Form SC 13G COLLEGIUM PHARMACEUTICAL Filed by: HealthCor Management, L.P.
-
Form SC 13D/A CareView Communications Filed by: HealthCor Management, L.P.
-
Form 4 HealthCor Partners LP For: Dec 31 Filed by: HealthCor Group, LLC
-
Form SC 13G Sagent Pharmaceuticals, Filed by: HealthCor Management, L.P.
-
Form 13F-HR HealthCor Management, For: Sep 30
-
Form SC 13G SeaSpine Holdings Corp Filed by: HealthCor Management, L.P.
-
HealthCore receives PCORI patient-based research award to advance understanding of patient health care experience
-
Form 4 CareView Communications For: Sep 30 Filed by: HealthCor Management, L.P.
-
Form 4 HealthCor Partners LP For: Sep 30 Filed by: HealthCor Group, LLC
-
Form SC 13D/A CareView Communications Filed by: HealthCor Management, L.P.
-
U.S. biotech bloodbath hits hedge funds but some bargains emerge
-
ReShape Medical, Inc. Completes $38 Million Series D Financing
-
CareView Communications Announces Second Quarter 2015 Financial Results
-
Form 13F-HR HealthCor Management, For: Jun 30
-
Form SC 13D/A CareView Communications Filed by: HealthCor Management, L.P.
-
Form 4 CareView Communications For: Jun 30 Filed by: HealthCor Associates, LLC
-
Editas Medicine Appoints Andrew Hack, M.D., Ph.D., as Chief Financial Officer
-
Form 13F-HR HealthCor Management, For: Mar 31
-
Form SC 13G Conatus Pharmaceuticals Filed by: HealthCor Management, L.P.
-
Natera, Inc., Non-Invasive Genetic Testing Leader, Secures $55 Million in Private Financing
-
Form SC 13D/A CareView Communications Filed by: HealthCor Management, L.P.
-
Form 4 CareView Communications For: Mar 31 Filed by: HealthCor Partners LP
-
Form SC 13D/A CareView Communications Filed by: HealthCor Management, L.P.
-
Form 4 CareView Communications For: Feb 17 Filed by: HealthCor Partners GP, LLC
-
Form 13F-HR HealthCor Management, For: Dec 31
-
Form SC 13G/A WRIGHT MEDICAL GROUP Filed by: HealthCor Management, L.P.
-
Form SC 13G/A eHealth, Inc. Filed by: HealthCor Management, L.P.
-
Form SC 13G/A DYNAVAX TECHNOLOGIES Filed by: HealthCor Management, L.P.
-
Form SC 13G/A TENAX THERAPEUTICS, INC. Filed by: HealthCor Management, L.P.
-
Form SC 13G/A FIVE PRIME THERAPEUTICS Filed by: HealthCor Management, L.P.
-
Form SC 13D/A CareView Communications Filed by: HealthCor Management, L.P.
-
Form 4 CareView Communications For: Dec 31 Filed by: HealthCor Partners LP
-
Form 13F-HR HealthCor Management, For: Sep 30
-
Form 4 CareView Communications For: Sep 30 Filed by: HealthCor Hybrid Offshore Master Fund, L.P.

